On
Notification for non-shareholders shall be made no later than
The Annual General Meeting will begin at
In addition to the above, please note that participation for non-shareholders requires formal approval from the meeting at the beginning of the annual general meeting.
For further information
Phone: +46 (0) 70 710 47 88
E-mail: gosta.lundgren@dextechmedical.com
See below formal notice of the Annual General Meeting
WELCOME TO THE ANNUAL GENERAL MEETING 2023
I DEXTECH MEDICAL AB (publ)
Tuesday
Admission to the Annual General Meeting begins at
Subject to space and that the meeting so decides, non-shareholders are also welcome to participate in the meeting without voting rights.
Registration and registration
Shareholders who wish to participate in the Annual General Meeting must:
· be entered in the share register maintained by
· Register with the company no later than
The notification must state the full name, personal or corporate identity number, shareholding, address, telephone number during the day and, where applicable, information about a deputy or assistant (maximum 2). The notification shall be accompanied, where appropriate, by powers of attorney, registration certificates and other documents of competence.
The Annual General Meeting will be held in Swedish.
Nominee registered shares
In order to be entitled to participate in the meeting, a person whose shares are registered in the name of a nominee must, through a nominee, have the shares registered in their own name, so that they are registered in the share register maintained by
Representatives, etc.
If shareholders are to be represented by a proxy, the proxy must have a written, dated and signed power of attorney for the meeting. The power of attorney may not be older than one year, unless a longer period of validity (but not more than five years) has been stated on the power of attorney. If the power of attorney is issued by a legal entity, the representative must also bring the current registration certificate or equivalent authorization documents for the legal entity. To facilitate entry, a copy of the power of attorney and other authorization documents should be attached to the notification to the meeting. Proxy forms are available on the company's website www.dextechmedical.com and sent by post to shareholders who contact the company and state their address.
Agenda
1. Election of chairman of the meeting.
2. Preparation and approval of the voting list.
3. Approval for non-shareholders to attend the meeting.
4. Approval of the agenda.
5. Choice of one or two persons to approve the minutes together with the President.
6. Determination of whether the meeting has been duly convened.
7. CEO's speech and a presentation of the clinical situation by Professor
8. Presentation of the annual report and auditor's report for the financial year 2022/2023.
9. Resolution on adoption of the profit and loss account and balance sheet.
10. Resolution on the appropriation of the company's profit or loss in accordance with the adopted balance sheet.
11. Resolution on discharge from liability for the members of the Board of Directors and the CEO.
12. Determination of the number of Board members, deputy Board members and, where applicable, the number of auditors or audit firms and any deputy auditors.
13. Determination of fees for the Board of Directors and the auditors.
14. Election of the Board of Directors, Chairman of the Board and any deputies.
15. Election of auditors or audit firms and any deputy auditors.
16. Any other business that is the responsibility of the meeting in accordance with the Swedish Companies Act, or
Articles of Association.
17. Closure of the meeting.
Proposal for a decision in brief
Determination of the number of Board members and deputy Board members (item 12)
According to the Articles of Association, the Board of Directors shall consist of a minimum of three and a maximum of seven members with a maximum of two deputies. Shareholders representing just over 60 percent of the total number of shares in the company have proposed that the number of Board members shall be five members and that no deputies be elected.
Determination of fees for the Board of Directors and auditors (item 13)
Shareholders representing just over 60% of the total number of shares in the company have proposed that Board fees shall be paid in the amount of
Election of the Board of Directors (item 14)
Shareholders representing more than 60% of the total number of shares in the company have proposed that the following persons be elected as Board members:
Re-election of Andreas Segerros,
Election of auditor (item 15)
Shareholders representing more than 60% of the total number of shares in the company have proposed re-election of
The Board's proposal
Appropriation of the Company's profit (item 10)
The funds at the disposal of the Annual General Meeting consist of profit for the year of SEK - 4,590,427, the Company's share premium fund of
The Board of Directors proposes that the funds at the disposal of the Annual General Meeting of
Shares and votes
The company has a total of 18,485,857 shares and an equal number of votes.
Documents
The annual report and auditor's report are available on the company's website www.dextechmedical.com.
__________________________
BOARD
https://news.cision.com/dextech/r/dextech-medical-ab--invitation-to-open-annual-general-meeting-and-notice,c3844417
https://mb.cision.com/Main/11652/3844417/2326839.pdf
(c) 2023 Cision. All rights reserved., source